Trademarkia Logo

Canada

C$
NEUROGIZER
APPROVED

on 3 Feb 2025

Last Applicant/ Owned by

PURAPHARM INTERNATIONAL (H.K.) LIMITED

Unit 201-207, 2/F, Wireless CentrePhase 1, HK Science ParkPak Shek Kok, Tai Po, New Territories,

HK

Serial Number

2026197 filed on 5th May 2020

Correspondent Address

COASTAL TRADEMARK SERVICES LIMITED

301-543 Granville StreetVancouver

BRITISH COLUMBIA

CA

V6C1X8

NEUROGIZER

Trademark usage description

nootropics, namely, dietary supplements for enhancing cognitive functionality and pharmaceuticals for enhancing cognitive functionality; nootropics, n Read More

Classification Information


Class [005]
Nootropics, namely, dietary supplements for enhancing cognitive functionality and pharmaceuticals for enhancing cognitive functionality; Nootropics, namely, dietary supplements containing green tea and lingzhi extracts for enhancing cognitive functionality; dietary supplements, namely, green tea extracts; dietary supplements, namely, lingzhi mushroom extracts; herbal food supplements for general health and well-being; herbal extract in the forms of capsule, tablet, powder and granule for general health and well-being; vitamins, vitamin preparations, minerals; enzyme preparations for medical purposes, namely, for use in the treatment of dyspepsia, corpulence, thrombosis, pancreatic disease, infant colic, wound debridement, dental plaque and gingivitis; enzyme preparations for veterinary purposes, namely, for use in the treatment of dyspepsia, corpulence and milk production; enzyme preparations, namely, enzyme dietary supplements for general health and well-being; dietary and nutritional supplements for general health and well-being; nutritional drink mixes in powder form, namely, nutritional supplement meal replacement drink mixes in powder form for general health and well-being; pharmaceutical and medicinal preparations and substances for the treatment and prevention of immune system related diseases and disorders, digestive diseases and disorders, central nervous system diseases and disorders, namely, brain diseases, movement disorders, ocular motility, respiratory diseases and disorders, excretory diseases and disorders, cardiovascular diseases and disorders, reproductive diseases and disorders, endocrinal diseases and disorders, immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndrome, hepatitis, dermatological diseases and disorders, skeletal diseases and disorders, namely, bone diseases, back pain, muscular diseases and disorders, namely, muscular dystrophy, inflammatory muscle diseases, sensory diseases and disorders, namely, blindness; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment and prevention of immune system related diseases and disorders, digestive diseases and disorders, central nervous system diseases and disorders, namely, brain diseases, movement disorders, ocular motility, respiratory diseases and disorders, excretory diseases and disorders, cardiovascular diseases and disorders, reproductive diseases and disorders, endocrinal diseases and disorders, immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndrome, hepatitis, dermatological diseases and disorders, skeletal diseases and disorders, namely, bone diseases, back pain, muscular diseases and disorders, namely, muscular dystrophy, inflammatory muscle diseases, sensory diseases and disorders, namely, blindness; dietetic food preparations, namely, dietetic sugar substitutes adapted for medical purposes; dietetic beverages adapted for medical purposes, namely, electrolyte replacement beverages for medical purposes; dietetic substances consisting of vitamins, minerals, amino acids and trace elements; dietetic food, beverages and substances adapted for medical use containing cannabinoids; dietetic food, beverages and substances adapted for medical use for general health and well-being; digestives for pharmaceutical purposes, namely, dietary fiber to aid digestion; medicinal drinks, namely, electrolyte drinks for medical purposes; appetite suppressants; dietary supplements for weight management; balms for medical purposes, namely, analgesic balms, antiseptic balms, medicated lip balm for the treatment of extremely chapped lips; lotions for pharmaceutical purposes, namely, antibiotics in the form of lotions, medicated lotions for sunburn, medicated diaper rash lotions; analgesics, sedatives, tranquilizers; sunburn ointments, sunburn preparations for pharmaceutical purposes; pharmaceutical preparations for the treatment of skin irritations, namely bee stings, sunburn, rashes, sores, corns, calluses, and acne; pharmaceutical preparations for skin care, namely, medicated skin care preparations for use as a moisturizer, medicated skin care preparations for use as a skin cleanser; medicinal mud, mud for baths; mouth washes for medical purposes; medicines for dental purposes, namely, medicated dental rinses; sanitary preparations for medical purposes, namely, disinfectants for medical apparatus and instruments; sanitary preparations for personal hygiene, namely, hand sanitizers, anti-bacterial soap, medicated antiperspirant soap; medicated deodorant soap; antiseptic shampoos; hair tonic for medical purpose, namely, medicinal hair growth preparations for healing, strengthening and nourishing hair; medicated antiseptic hair conditioner; veterinary nutritional supplements, namely, animal feed supplements for veterinary purposes and medicated preparations for animals, namely, antibiotics, vitamins for veterinary purposes; anti-infective preparations for veterinary purposes; medicated shampoos for use with animals, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; all purpose disinfectants; preparations for destroying vermin; fungicides, herbicides


Classification kind code

12

Mark Details


Serial Number

2026197

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 26
on 3rd Feb 2025
Approved
Submitted for opposition 27
on 3rd Feb 2025
Approval Notice Sent
Submitted for opposition 22
on 8th Jul 2024
Search Recorded
Submitted for opposition 20
on 8th Jul 2024
Examiner's First Report
Submitted for opposition 135
on 9th May 2023
Amendment to Application
Submitted for opposition 287
on 16th Jun 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 5th May 2020
Filed
Submitted for opposition 1
on 5th May 2020
Created
Submitted for opposition 31
on 5th May 2020
Formalized